Canopy Growth Corp

Canopy Growth’s $125 million MTL Cannabis deal expands its Quebec production, boosts CBD‑rich product lines and positions it for U.S. market access as cannabis reclassifies. Click to see the strategic gains.

Canopy Growth Corp’s stock faces volatility amid regulatory shifts and new product rollouts—investors eye board actions, cash flow, and rising demand for medical cannabis.

Unable to generate article: the news items lack data on Canopy Growth Corp. No content available.